Regulation of lipid accumulation by AMK-Activated kinase in high fat diet-induced kidney injury

Kidney International

Volumn 85, Issue 3, 2014, Pages 611-623

  Declèves, Anne Emilie ^a,b,c   Zolkipli, Zarazuela ^d   Satriano, Joseph ^a,b   Wang, Lin ^d   Nakayama, Tomohiro ^d   Rogac, Mihael ^d   Le, Thuy P ^d   Nortier, Joëlle L ^c   Farquhar, Marilyn G ^a   Naviaux, Robert K ^d   Sharma, Kumar ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

AMPK; chronic kidney disease; lipid accumulation; lysosomal dysfunction; obesity

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ADIPONECTIN; CHOLESTEROL ESTER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; 5 AMINO 4 IMIDAZOLECARBOXAMIDE; AICA RIBONUCLEOTIDE; CHOLESTEROL; RIBONUCLEOTIDE;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL VACUOLE; CHOLESTEROL METABOLISM; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENZYME ACTIVATION; GENE EXPRESSION; GLOMERULUS FILTRATION; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KIDNEY FUNCTION TEST; KIDNEY HYPERTROPHY; KIDNEY INJURY; KIDNEY PARENCHYMA; KIDNEY TUBULE CELL; LIPID DIET; LIPID METABOLISM; LIPID OXIDATION; LIPID STORAGE; LYSOSOME; LYSOSOME MEMBRANE; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; ANIMAL CELL; ENZYME ACTIVITY; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY TUBULE DAMAGE; LIPID ANALYSIS; MOLECULAR PATHOLOGY; PATHOLOGICAL ANATOMY; PHOSPHOLIPID METABOLISM; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; KIDNEY; METABOLISM; MITOCHONDRION; PATHOLOGY; PHYSIOLOGY;

ALBUMINURIA; AMINOIMIDAZOLE CARBOXAMIDE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CHOLESTEROL; DIET, HIGH-FAT; INSULIN RESISTANCE; KIDNEY; LIPID METABOLISM; MICE, INBRED C57BL; MITOCHONDRIA; OBESITY; RIBONUCLEOTIDES;

EID: 84895078856     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.462     Document Type: Article

References (41)

1. Collins AJ, Foley RN, Herzog C et al. US Renal Data System 2010 Annual Data Report. American journal of kidney diseases: the official journal of the National Kidney Foundation 2011; 57(1 Suppl 1): A8, e1-526
2. Marcussen N. Atubular glomeruli and the structural basis for chronic renal failure. Lab Invest 1992; 66: 265-284
3. Taft JL, Nolan CJ, Yeung SP et al. Clinical and histological correlations of decline in renal function in diabetic patients with proteinuria. Diabetes 1994; 43: 1046-1051
4. Gilbert RE, Cooper ME. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int 1999; 56: 1627-1637
5. Chagnac A, Weinstein T, Korzets A et al. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol 2000; 278: F817-F822
6. Decleves AE, Mathew AV, Cunard R et al. AMPK mediates the initiation of kidney disease induced by a high-fat diet. J Am Soc Nephrol 2011; 22: 1846-1855
7. Stapleton D, Mitchelhill KI, Gao G et al. Mammalian AMP-Activated protein kinase subfamily. J Biol Chem 1996; 271: 611-614
8. Yamauchi T, Kamon J, Ito Y et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003; 423: 762-769
9. Steinberg GR, Kemp BE. AMPK in health and disease. Physiol Rev 2009; 89: 1025-1078
10. Laurent G, Carlier MB, Rollman B et al. Mechanism of aminoglycosideinduced lysosomal phospholipidosis: in vitro and in vivo studies with gentamicin and amikacin. Biochem Pharmacol 1982; 31: 3861-3870
11. De Broe ME, Paulus GJ, Verpooten GA et al. Early effects of gentamicin, tobramycin, and amikacin on the human kidney. Kidney Int 1984; 25: 643-652
12. Carling D. The AMP-Activated protein kinase cascade-A unifying system for energy control. Trends Biochem Sci 2004; 29: 18-24
13. Hardie DG, Hawley SA, Scott JW. AMP-Activated protein kinase- development of the energy sensor concept. J Physiol 2006; 574(Pt 1): 7-15
14. Woods A, Dickerson K, Heath R et al. Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-Activated protein kinase in mammalian cells. Cell Metabol 2005; 2: 21-33
15. Maunsbach AB. The influence of different fixatives and fixation methods on the ultrastructure of rat kidney proximal tubule cells. I. Comparison of different perfusion fixation methods and of glutaraldehyde, formaldehyde and osmium tetroxide fixatives.. J Ultrastruct Res 1966; 15: 242-282
16. Maunsbach AB. The influence of different fixatives and fixation methods on the ultrastructure of rat kidney proximal tubule cells. II. Effects of varying osmolality, ionic strength, buffer system and fixative concentration of glutaraldehyde solutions. J Ultrastruct Res 1966; 15: 283-309
17. Maunsbach AB. Observations on the segmentation of the proximal tubule in the rat kidney. Comparison of results from phase contrast, fluorescence and electron microscopy. J Ultrastruct Res 1966; 16: 239-258
18. Jiang T, Liebman SE, Lucia MS et al. Role of altered renal lipid metabolism and the sterol regulatory element binding proteins in the pathogenesis of age-related renal disease. Kidney Int 2005; 68: 2608-2620
19. Deji N, Kume S, Araki S et al. Structural and functional changes in the kidneys of high-fat diet-induced obese mice. Am J Physiol Renal Physiol 2009; 296: F118-F126
20. Kume S, Uzu T, Araki S et al. Role of altered renal lipid metabolism in the development of renal injury induced by a high-fat diet. J Am Soc Nephrol 2007; 18: 2715-2723
21. Beauchamp D, Laurent G, Maldague P et al. Protection against gentamicin-induced early renal alterations (phospholipidosis and increased DNA synthesis) by coadministration of poly-L-Aspartic acid. J Pharmacol Exp Ther 1990; 255: 858-866
22. Aubert-Tulkens G, Van Hoof F, Tulkens P. Gentamicin-induced lysosomal phospholipidosis in cultured rat fibroblasts. Quantitative ultrastructural and biochemical study. Lab Invest 1979; 40: 481-491
23. Fillastre JP, Hemet J, Tulkens P et al. Comparative nephrotoxicity of four aminoglycosides: biochemical and ultrastructural modifications of lysosomes. Adv Nephrol Necker Hosp 1983; 12: 253-275
24. Houghton DC, Lee D, Gilbert DN et al. Chronic gentamicin nephrotoxicity. Continued tubular injury with preserved glomerular filtration function. Am J Pathol 1986; 123: 183-194
25. Giuliano RA, Paulus GJ, Verpooten GA et al. Recovery of cortical phospholipidosis and necrosis after acute gentamicin loading in rats. Kidney Int 1984; 26: 838-847
26. Giurgea-Marion L, Toubeau G, Laurent G et al. Impairment of lysosomepinocytic vesicle fusion in rat kidney proximal tubules after treatment with gentamicin at low doses. Toxicol Appl Pharmacol 1986; 86: 271-285
27. Singh R, Kaushik S, Wang Y et al. Autophagy regulates lipid metabolism. Nature 2009; 458: 1131-1135
28. Hulkova H, Elleder M. Distinctive histopathological features that support a diagnosis of cholesterol ester storage disease in liver biopsy specimens. Histopathology 2012; 60: 1107-1113
29. Wu G, Liu L, Huang J et al. Alterations of autophagic-lysosomal system in the peripheral leukocytes of patients with myocardial infarction. Clin Chim Acta 2011; 412: 1567-1571
30. Jiang M, Wei Q, Dong G et al. Autophagy in proximal tubules protects against acute kidney injury. Kidney Int 2012; 82: 1271-1283
31. Kaushal GP. Autophagy protects proximal tubular cells from injury and apoptosis. Kidney Int 2012; 82: 1250-1253
32. Papackova Z, Dankova H, Palenickova E et al. Effect of short- and longterm high-fat feeding on autophagy flux and lysosomal activity in rat liver. Physiol Res 2012; 61(Suppl 2): S67-S76
33. Koga H, Kaushik S, Cuervo AM. Altered lipid content inhibits autophagic vesicular fusion. FASEB J 2010; 24: 3052-3065
34. Mei S, Ni HM, Manley S et al. Differential roles of unsaturated and saturated fatty acids on autophagy and apoptosis in hepatocytes. J Pharmacol Exp Ther 2011; 339: 487-498
35. Ruggiero C, Ehrenshaft M, Cleland E et al. High-fat diet induces an initial adaptation of mitochondrial bioenergetics in the kidney despite evident oxidative stress and mitochondrial ROS production. Am J Physiol Endocrinol Metabol 2011; 300: E1047-E1058
36. Corton JM, Gillespie JG, Hawley SA et al. 5-Aminoimidazole-4- carboxamide ribonucleoside. A specific method for activating AMPactivated protein kinase in intact cells? Eur J Biochem 1995; 229: 558-565
37. Takeda T, McQuistan T, Orlando RA et al. Loss of glomerular foot processes is associated with uncoupling of podocalyxin from the actin cytoskeleton. J Clin Invest 2001; 108: 289-301
38. Decleves AE, Caron N, Nonclercq D et al. Dynamics of hyaluronan, CD44, and inflammatory cells in the rat kidney after ischemia/reperfusion injury. Int J Mol Med 2006; 18: 83-94
39. Hatefi Y. Reconstitution of the electron-transport system of bovine heart mitochondria. Methods Enzymol 1978; 53: 48-54
40. Wharton DC, Tzagoloff A. Cytochrome oxidase from beef heart. Methods Enzymol 1967; 10: 245-250
41. Shepherd D, Garland PB. Citrate synthase from rat liver. Methods Enzymol 1969; 13: 11-16.